Overview
A non-invasive blood glucose monitor is a medical or consumer device used to measure glucose levels in the body without penetration, pin-pricks, or implanting devices. Non-invasive blood glucose monitoring systems typically function by detecting glucose levels through the skin or any tissue using advanced approaches like optical spectroscopy, transdermal sensing, electromagnetic, or thermal approaches. The primary goal of using non-invasive blood glucose monitoring systems is to provide a painless, easy, real-time way to monitor blood glucose which can advance diabetes care, improve adherence, and increase accessibility for those who want an easy and painless way to monitor blood glucose for either patients who have diabetes or health-conscious individuals who want to track their health continuously.

To learn more about this report, download the PDF brochure
Rising diabetes prevalence & ageing populations to drive market growth
Growing obesity globally and an ageing population means that the prevalence of diabetes is rising, thereby driving demand for non-invasive blood glucose monitoring systems. According to WHO, the number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022, with prevalence rising more rapidly in low- and middle-income countries than in high-income countries. As cases of diabetes increase due to lifestyle and longevity, there are rising instances of people needing more frequent, accurate and easier glucose monitoring. Further, the demand for glucose measurement tools is especially prevalent among aging populations who have diabetes and/or are prone to diabetes. The need for less painful, noninvasive glucose measurement is part of a larger trend in medical diagnosis where users want to remove finger pricks from diabetic care as much as possible. The better the disease management is while prioritizing comfort and convenience, the higher the adoption level is and thus, the better the innovation and growth in the market globally.

To learn more about this report, download the PDF brochure
Integration with wearables to present a lucrative market opportunity
Integration with wearables is becoming a prominent trend in the non-invasive blood glucose monitoring system market and it is changing the way users track their health. By placing glucose sensors in smartwatches and fit bands, manufacturers allow tracking glucose levels at all times without adding another device and having the sensor be integrated seamlessly into their daily habits. This added integration is attractive to both diabetes patients and wellness/mindfulness consumers who want to monitor and record their health with the added benefits of wearing the monitoring device on their wrists, allowing for a more convenient and less invasive method for obtaining alerts and insight into lifestyle choices to inform future decisions. In partnership with mobile apps and cloud technology, wearables provide a method to engage users through entertainment, support preventive health, provide access to glucose related data, and guide to adoption of lifestyle and health changes, these factors all together are impacting growth of this evolving market.
Competitive Landscape Analysis
The global non-invasive blood glucose monitoring system market is marked by the presence of established and emerging market players such as Abbott, Medtronic, Afon Technology Ltd., Senseonics, Cnoga, GlucoRx Limited, DiaMonTech AG, Nemaura Medical, DiaMonTech AG, and Know Labs, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 20% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | By Technology, Device Type, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Abbott, Medtronic, Afon Technology Ltd., Senseonics, Cnoga, GlucoRx Limited, DiaMonTech AG, Nemaura Medical, DiaMonTech AG, and Know Labs, Inc. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Non-invasive Blood Glucose Monitoring System Market Segmentation
This report by Medi-Tech Insights provides thesize of the global non-invasive blood glucose monitoring system market at theregional- and country-level from 2023 to 2030. The report further segments the market based on technology, device type, application, and end user.
Market Size & Forecast (2023-2030), By Technology, USD Million
- Optical Methods
- Transdermal Methods
- Electromagnetic Sensing
- Others
Market Size & Forecast (2023-2030), By Device Type, USD Million
- Wearables
- Non-wearable
Market Size & Forecast (2023-2030), By Application, USD Million
- Diabetes Management
- Wellness & Preventive Healthcare
- Critical/Acute Care Monul>
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals & Clinics
- Homecare Settings
- Fitness & Wellness Centers
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the non-invasive blood glucose monitoring system market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the non-invasive blood glucose monitoring system market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Related Reports
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.